ARWR Stock Analysis: Buy, Sell, or Hold?
ARWR - Arrowhead Research Corporation
$72.14
-0.86 (-1.18%)
▼
5d:
+7.82%
30d:
+6.42%
90d:
+70.18%
BUY
MODERATE Confidence
Last Updated: February 3, 2026
Earnings: Feb 05, 2026
TODAY
Get Alerted When ARWR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
4 traders called ARWR this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ARWR shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: ARWR shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ARWR is currently trading at $72.14, which is considered extended relative to its 30-day fair value range of $64.95 to $69.75.
Technical Outlook: Technically, ARWR is in a strong uptrend. Immediate support is located at $65.23, while resistance sits at $76.11.
Market Sentiment: ARWR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $81.92 (+13.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ARWR is in a strong uptrend. Immediate support is located at $65.23, while resistance sits at $76.11.
Market Sentiment: ARWR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $81.92 (+13.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$64.95 -
$69.75
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($81.92)
Fair Price Analysis
30-Day Fair Range
$64.95 -
$69.75
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$65.23
Resistance Level
$76.11
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-16.43
Wall Street Target
$81.92
(+13.6%)
Revenue Growth (YoY)
-29.6%
Earnings Growth (YoY)
9.8%
Profit Margin
-0.2%
Last updated: February 04, 2026 7:25 AM ET
Data refreshes hourly during market hours. Next update: 8:25 AM
Data refreshes hourly during market hours. Next update: 8:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARWR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
James C Hamilton
SELL
20000 shares
2025-10-01
James C Hamilton
SELL
15000 shares
2025-09-12
James C Hamilton
SELL
15000 shares
2025-09-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$93 | 59 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$34 | 57 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$108 | 60 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$71 | 62 BUY |
Advanced ARWR Option Strategies
Professional options setups generated by AI based on today's ARWR price and gamma walls.
